Vireo Growth (VREOF) Revenue (2020 - 2026)
Vireo Growth (VREOF) reported Revenue of $106.2 million for Q1 2026, up 333.47% on a YoY basis from $24.5 million in Q1 2025, and up 1.62% sequentially from $104.5 million in Q4 2025.
Vireo Growth (VREOF) Revenue (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Revenue data on file, last reported at $106.2 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 333.47% year-over-year to $106.2 million; the trailing twelve-month figure through Mar 2026 stood at $350.4 million (up 251.14% YoY), and the FY2025 full-year result was $268.8 million, up 170.43% from the prior year.
- Revenue grew to $106.2 million in Q1 2026, from $104.5 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $106.2 million in Q1 2026 to a low of $15.6 million in Q1 2022.
- A 5-year average of $37.5 million and a median of $24.5 million in 2025 frame the typical range for Revenue.
- Across the five-year window, Revenue slipped 4.24% in 2023 and jumped 333.47% in 2026, its largest moves.
- Tracing VREOF's Revenue over 5 years: stood at $19.0 million in 2022, then advanced by 26.94% to $24.2 million in 2023, then grew by 3.52% to $25.0 million in 2024, then soared by 317.65% to $104.5 million in 2025, then advanced by 1.62% to $106.2 million in 2026.
- Business Quant data shows VREOF's Revenue at $106.2 million in Q1 2026, $104.5 million in Q4 2025, and $91.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 106.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.20 Mn |
| Dec 31, 2025 | 104.51 Mn |
| Sep 30, 2025 | 91.66 Mn |
| Jun 30, 2025 | 48.06 Mn |
| Mar 31, 2025 | 24.50 Mn |
| Dec 31, 2024 | 25.02 Mn |
| Sep 30, 2024 | 25.17 Mn |
| Jun 30, 2024 | 25.11 Mn |
| Mar 31, 2024 | 24.09 Mn |
| Dec 31, 2023 | 24.17 Mn |
| Sep 30, 2023 | 24.68 Mn |
| Jun 30, 2023 | 20.20 Mn |
| Mar 31, 2023 | 19.09 Mn |
| Dec 31, 2022 | 19.04 Mn |
| Sep 30, 2022 | 18.85 Mn |
| Jun 30, 2022 | 21.09 Mn |
| Mar 31, 2022 | 15.64 Mn |
| Dec 31, 2021 | 13.66 Mn |
| Sep 30, 2021 | 13.37 Mn |
| Jun 30, 2021 | 14.23 Mn |